Navigation Links
Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
Date:8/19/2007

SAN DIEGO, Aug. 14 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today unaudited financial results for the second quarter and six months ended June 30, 2007. Cadence reported a net loss for the second quarter of 2007 of $14.9 million, or $0.52 per share, compared to a net loss of $6.2 million, or $4.92 per share, in the second quarter of 2006. For the six months ended June 30, 2007, the company reported a net loss of $24.5 million, or $0.86 per share, compared to a net loss of $35.4 million, or $28.50 per share for the six months ended June 30, 2006.

As of June 30, 2007, Cadence held cash and cash equivalents of $66.9 million.

"We remain keenly focused on executing the development programs for our two Phase III product candidates, intravenous acetaminophen and Omigard(TM)," said Ted Schroeder, Cadence's President and Chief Executive Officer. "As a result, we are on track to meet our clinical development and pre-commercialization manufacturing objectives for both product candidates. In particular, we are pleased with the recent execution of a development and supply agreement for IV acetaminophen with Baxter Healthcare, a leading global contract manufacturer, which we believe will position us to meet the anticipated demand for this important product candidate upon commercialization and for several years thereafter."

Financial Results

Total operating expenses for the second quarter of 2007 were $15.7 million, compared to $6.6 million for the second quarter of 2006. The increase in operating expenses was p
'/>"/>

SOURCE Cadence Pharmaceuticals, Inc.

Copyright©2007 PR Newswire.

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Deltanoid Pharmaceuticals begins phase II osteoporosis study
2. The Coming of Biotech Generic Pharmaceuticals
3. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
4. Sonic Foundry reports GAAP loss as Q2 revenues rise
5. Fiserv reports $113.5 million in Q1 profit
6. Third Wave reports net loss of $18.9M for 2006
7. Musicnotes reports 45 percent growth in 2006
8. Sonic Foundry reports net loss, higher revenue
9. Sonic Foundry reports first cash-positive quarter
10. Merge Healthcare reports $10.8M net loss in Q3
11. Third Wave reports $5.2M third quarter loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...wire-FirstCall/ -- eResearchTechnology, Inc.,(eRT...lized ECG and eClinical,technology, ePRO and othe...medical device and related industries, announced t...President and Chief Executive Officer, and Keith,...e scheduled to present at,the Piper Jaffray Healt...
(Date:12/2/2008)...wswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical,...nd supplier,of modernized traditional Chinese med...unced the implementation of a new sales and market...hospital clients into three classes in order,to o... The new strategy has classified distributors i...
(Date:12/2/2008)...RNewswire/ -- GeneGo, Inc., the leading systems bi...has become a certified GeneGo Center of Excellence...ccess to GeneGo,s MetaCore data analysis suite, tr...e is a world-class biomedical research facility ru...ut many departments, including research in cancer,...
(Date:12/2/2008)..., December 2 NicOx S.A.,... signed an agreement with,DSM for the commercial ...ce,(or API, active pharmaceutical ingredient). Na...and the first compound in the,Cyclooxygenase-Inhi...i-inflammatory agents, which recently achieved pos...
Breaking Biology Technology:eResearchTechnology, Inc. to Present at the Piper Jaffray Health Care Conference on December 2, 2008 2Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth 2Tianyin Pharmaceutical Co., Inc. Implements New Sales and Marketing Strategy to Drive Revenue Growth 3The Burnham Institute for Medical Research Becomes a GeneGo Center of Excellence Using MetaCore for Stem Cell Research and Neurology 2NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 2NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 3NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance 4
...d flags in Midwest technology job offers and made ...ctive employer is someone who,s worth your time. ,...ing (even something small like a minor salary bump... see whether the company,s response to candidates ...,We heard from Nine2Five reader and local techno...
...Though California recently made the extraordinary ...esearch in the wake of President Bushs policy (whi...t-associated research in this area), Wisconsin is ...sconsin is also the state where the University of ...h Foundation (WARF) hold the key patents. , ,Wisco...
...ught all outstanding stock of Texas-based VectorS...ctions and check image processing. , ,Metavante, a...tober that it would buy VectorSGIs stock for $100 ... owned subsidiary. The move followed Metavantes ac... company that works on electronic check imaging. ,...
...e Sec. Cory Nettles to talk about aiding entrepren...ommerce will fund a public-sector coalition to pro...r assistance at centers around the state, Governor...will provide $1 million per year for five years, h...er contributions this year. After a competitive bi...
Other Biology Technology:One reader asked for more, and got it 2One reader asked for more, and got it 3One reader asked for more, and got it 4One reader asked for more, and got it 5Third coast of biotechnology makes strong showing at VC conference 2Third coast of biotechnology makes strong showing at VC conference 3Third coast of biotechnology makes strong showing at VC conference 4Third coast of biotechnology makes strong showing at VC conference 5State and university form network for entrepreneurial outreach 2State and university form network for entrepreneurial outreach 3
(Date:12/2/2008)... , Performing systematic reviews of nutrition rel...ountered in the field of medicine. In a new articl...describe the steps, strengths, and limitations of ...ss the factors that impact the results. , Syste...reviews, provide objective assessments with pre-sp...
(Date:12/1/2008)... , Vienna, 2 December 2008 - The International At...ed investment in a plant breeding technique that c...people out of the hunger trap. , IAEA scientists...lants that adapt to harsh climate conditions such ...ain diseases and insect pests. Called mutation ind...
(Date:12/1/2008)... , STANFORD, Calif. Scientists around the world m... for free online, that will help them to home in o...unction. , Arend Sidow, PhD, associate professor...ersity School of Medicine, recently launched the n...as the guide to determining the role different pro...
(Date:12/1/2008)... , GAINESVILLE, Fla. The University of Florida, ...o now overseeing a national records collection for...Distinguished by a long rostrum or "saw" that make...he sawfish has become a historical and cultural ic...ss, a UF ichthyologist and curator of both the Int...
Breaking Biology News(10 mins):Experts discuss applying systematic review to the field of nutrition 2Nuclear science for food security 2Powerful online tool for protein analysis provided pro bono by Stanford geneticist 2Powerful online tool for protein analysis provided pro bono by Stanford geneticist 3Endangered sawfish focus of national collection and recovery efforts 2Arbios Announces SEPET 28TM 29 Manufacturing Agreement With NxStage Medical 1430 1Arbios Announces SEPET 28TM 29 Manufacturing Agreement With NxStage Medical 1430 2Arbios Announces SEPET 28TM 29 Manufacturing Agreement With NxStage Medical 1430 3Arbios Announces SEPET 28TM 29 Manufacturing Agreement With NxStage Medical 1430 4Ground Breaking Conference Takes on Abortion 1427 1Ground Breaking Conference Takes on Abortion 1427 2Epidemic of Anesthesia Overdosing How Can You Avoid It 3F 4334 1Epidemic of Anesthesia Overdosing How Can You Avoid It 3F 4334 2Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 4333 1Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 4333 2Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 4333 3Microsoft and HIMSS Expanding Healthcare User Group Across EMEA 4333 4
...itute (BTI) researcher at Cornell University has r... of DNA mutations in maize (corn). , The project ...ts of knocking out the function of single genes, o...mutation, or disrupted gene. The seeds will be mad... lines could one day lead to plants with tailor-ma...
...ark Pagani in the Department of Geology and Geophy...etailed history of atmospheric carbon dioxide betw...opes of carbon in a National Science Foundation st...ergy we consume, each of us makes a contribution t...xide and methane, in the Earth,s atmosphere," said...
...bodies demonstrate enhanced cell killing compared ..., Origen Therapeutics today announced the first p...man sequence monoclonal antibodies (mAbs) produced... in the chicken oviduct and deposited into egg whi...reover, antibodies produced in this manner demonst...
... polio have today been announced in Yemen, bringin...break in the country to 22. Yemen had been polio-f...enetic investigation is ongoing to determine the p...he number of cases will rise in the immediate futu...logists and paediatricians remain on the ground, t...
Other Biology News:Researcher gets NSF grant to create mutant maize lines 2Researcher gets NSF grant to create mutant maize lines 3Stem cells grown in lab mirror normal developmental steps 2First production of human monoclonal antibodies in chicken eggs published in Nature Biotechnology 2First production of human monoclonal antibodies in chicken eggs published in Nature Biotechnology 3New Vaccine To Be Used For First Time In Polio Outbreak Response 2
...esign, The Bioactive peptides are molecules of pe... behaviour or activity which can be developed at t..., chemical and agro-food applications. In this way...uperior properties for therapeutic applications. P...
... Bovine IFNγ ELISPOT (enzyme-lined immunospo...uction at the single cell level. A spot forms at t...ed (either using a dissection microscope or automa...r of cells added to the microplate. This allows th...
... Frame DNAscope is an integrated confocal laser sc...eadily integrated into your specific application. ...or we can tailor the system to your specifications...ing design has been modularized and built onto an ...
...Pix Professional 4200A can be upgraded to the Gene...matically loads, scans, analyzes, and saves result...when the batch is complete. Line-by-line autofocus...d slides. GenePix Pro gives you complete flexibili...
Biology Products: